| Prev Close | 8.14 |
| Open | 7.56 |
| Day Low/High | 7.28 / 7.56 |
| 52 Wk Low/High | 3.08 / 8.18 |
| Volume | 4.41K |
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Class H (SFOSF)
7.42
0.72
8.85
OTC
| Exchange | OTC |
| Shares Outstanding | 2562.90B |
| Market Cap | 16.79B |
| Div & Yield | N.A. (N.A) |
Lies, damn lies, and statistics in the vaccine age, as Hong Kong and Macau stop administering the Pfizer/BioNTech drug.
When the central bank is on top of their game as they have been of late, credit must go where credit is due.
Any modest intraday dip is probably a buying opportunity.
Despite a summer of violent protests, it appears Hong Kong's talked-off demise as a market for initial public offerings may well be overstated.
Chinese authorities are auditing the books of 77 drugmakers, including three multinationals, they say were selected at random. Were they motivated by embarrassment over a college-admissions payment made by a Chinese pharmaceuticals' tycoon?